Stockreport

Nurix Therapeutics Announces Appointment of John Northcott as Chief Commercial Officer [Yahoo! Finance]

Nurix Therapeutics, Inc. - Common stock  (NRIX) 
PDF Mr. Northcott brings over 20 years of biopharmaceutical experience building commercial organizations and successfully commercializing novel products, including BTK inhi [Read more]